A COMPARATIVE-STUDY OF ENDOTHELIN AND SARAFOTOXIN ACTION IN VASCULAR AND NONVASCULAR SMOOTH-MUSCLE

被引:8
|
作者
ETA, E [1 ]
TRIGGLE, CR [1 ]
机构
[1] MEM UNIV NEWFOUNDLAND, FAC MED,DIV BASIC MED SCI, St John A1B 3V6, NEWFOUNDLAND, CANADA
关键词
D O I
10.1016/0197-0186(91)90156-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of endothelin and sarafotoxin on smooth muscle tone have been examined in the rat aorta and anococcygeus muscle and their actions compared to those of norepinephrine. The contractions elicited by endothelin and sarafotoxin (10 nM), or norepinephrine (1-mu-M) were approximately equieffective in terms of tension development and correspond to EC50 values and these concentrations were thus used throughout the study. In calcium-free Krebs the three agonist generated approximately similar levels of tone in the aorta and the anococcygeus corresponding to 20 and 5% of the maximum response, respectively. Nifedipine, 10-mu-M, significantly inhibited responses to endothelin and norepinephrine in the aorta but only norepinephrine in anococcygeus; the responses to sarafotoxin were however not significantly affected in either tissue. A combination of 10-mu-M ryanodine and nifedipine caused near complete inhibition of the response to endothelin in the aorta and also significantly reduced the response to both endothelin and norepinephrine in the anococcygeus. The lipoxgenase inhibitor, nordihydroguaiaretic acid, inhibited the response to endothelin in the aorta and endothelin and norepinephrine in the anococcygeus muscle. The cyclooxygenase inhibitor, indomethacin, however, had no effect on the responses to any of the three agonists in either the aorta or anococcygeus. At concentrations greater than 30 nM both endothelin and sarafotoxin induced myogenic activity in normally quiescent anococcygeus muscle. As determined by the loss of myogenic activity the tissues recovered more rapidly from sarafotoxin than endothelin with complete recovery apparent after 2.62 +/- 0.85 and 5.22 +/- 0.06 h respectively. Omitting Ca2+ from the Krebs solution reduced recovery times to 1.62 +/- 0.2 and 2.4 +/- 0.51 h respectively. Overall the results suggest that endothelin and sarafotoxin activate different cell signaling systems to differing extents in rat aorta versus anococcygeus suggesting that the membrane receptors mediating the responses to endothelin and sarafotoxin are not necessarily identical.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
  • [11] ENDOTHELIN, A POTENT VASOCONSTRICTOR, IS A VASCULAR SMOOTH-MUSCLE MITOGEN
    DUBIN, D
    PRATT, RE
    COOKE, JP
    DZAU, VJ
    CLINICAL RESEARCH, 1989, 37 (02): : A517 - A517
  • [12] THE MECHANISM OF ACTION OF ENDOTHELIN-1 AS COMPARED WITH OTHER AGONISTS IN VASCULAR SMOOTH-MUSCLE
    WALLNOFER, A
    WEIR, S
    RUEGG, U
    CAUVIN, C
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S23 - S31
  • [13] BIOACTIVATION OF NITROGLYCERIN IN VASCULAR SMOOTH-MUSCLE CELLS IS DIFFERENT FROM THAT IN NONVASCULAR TISSUE
    BRAUN, M
    GROSSER, T
    SCHROR, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 276 (03) : 239 - 245
  • [14] UNEVEN DISTRIBUTION OF MYOSIN LIGHT CHAIN ISOFORMS IN VASCULAR AND NONVASCULAR SMOOTH-MUSCLE
    HATHAWAY, DR
    HELPER, DJ
    CIRCULATION, 1987, 76 (04) : 243 - 243
  • [15] ON THE MECHANISM OF ACTION OF PINACIDIL ON THE VASCULAR SMOOTH-MUSCLE
    KAZIC, T
    RADULOVIC, S
    GOJKOVIC, L
    IUGOSLAVICA PHYSIOLOGICA ET PHARMACOLOGICA ACTA, 1989, 25 (03) : 313 - 317
  • [16] MECHANISM OF ACTION OF HYDRALAZINE ON VASCULAR SMOOTH-MUSCLE
    JACOBS, M
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (18) : 2915 - 2919
  • [17] CELLULAR MECHANISM OF ACTION BY A NOVEL VASOCONSTRICTOR ENDOTHELIN IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS
    HIRATA, Y
    YOSHIMI, H
    TAKATA, S
    WATANABE, TX
    KUMAGAI, S
    NAKAJIMA, K
    SAKAKIBARA, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) : 868 - 875
  • [18] MECHANISM OF SIGNAL TRANSDUCTION BY ENDOTHELIN IN VASCULAR SMOOTH-MUSCLE CELLS
    IVES, HE
    MORRIS, RC
    MITSUHASHI, T
    CLINICAL RESEARCH, 1989, 37 (02): : A395 - A395
  • [19] INHIBITION OF ENDOTHELIN PRODUCTION BY ADRENOMEDULLIN IN VASCULAR SMOOTH-MUSCLE CELLS
    KOHNO, M
    KANO, H
    HORIO, T
    YOKOKAWA, K
    YASUNARI, K
    TAKEDA, T
    HYPERTENSION, 1995, 25 (06) : 1185 - 1190
  • [20] REGULATION OF ENDOTHELIN RECEPTOR EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS
    YU, JCM
    DAVENPORT, AP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S348 - S350